Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients. Highlights include: Why partnerships are an important part of this journeyHow a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosisWhy pharma leaders should experiment with...
All content for Transforming Biopharma is the property of ZS and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients. Highlights include: Why partnerships are an important part of this journeyHow a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosisWhy pharma leaders should experiment with...
Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients. Highlights include: Why partnerships are an important part of this journeyHow a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosisWhy pharma leaders should experiment with...
